Search by Drug Name or NDC

    NDC 16714-0893-01 Lamotrigine 250 mg/1 Details

    Lamotrigine 250 mg/1

    Lamotrigine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NorthStar Rx LLC. The primary component is LAMOTRIGINE.

    Product Information

    NDC 16714-0893
    Product ID 16714-893_3fca77cd-0645-d615-fd67-34db69aa44fa
    Associated GPIs 72600040007545
    GCN Sequence Number 068093
    GCN Sequence Number Description lamotrigine TAB ER 24 250 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 30787
    HICL Sequence Number 007378
    HICL Sequence Number Description LAMOTRIGINE
    Brand/Generic Generic
    Proprietary Name Lamotrigine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lamotrigine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name LAMOTRIGINE
    Labeler Name NorthStar Rx LLC
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202383
    Listing Certified Through 2024-12-31

    Package

    NDC 16714-0893-01 (16714089301)

    NDC Package Code 16714-893-01
    Billing NDC 16714089301
    Package 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-893-01)
    Marketing Start Date 2018-11-20
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 2.11947
    Pricing Unit EA
    Effective Date 2024-01-17
    NDC Description LAMOTRIGINE ER 250 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis